We are developing breakthrough technology for rapid, individualized, non-invasive treatment of major depression. A randomized controlled trial just published in the American Journal of Psychiatry showed relief of severe depression in 79% of people receiving active treatment. Read the Press Release
FDA awards Breakthrough Device Designation
The FDA has awarded Breakthrough Device Designation to Magnus Medical’s non-invasive technology to rapidly treat major depressive disorder (MDD) in adults who have not responded to existing treatments.